Insulet estimated that its total addressable market for automated insulin delivery will grow to a $9bn market value by 2028.

Fintel reports that on January 12, 2026, Barclays downgraded their outlook for Insulet (NasdaqGS:PODD) from Equal-Weight to ...

Insulet’s fair value estimate has been held steady at US$377.72 per share, with only fractional tweaks to the underlying ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks ...

Detailed price information for C.H. Robinson Ww (CHRW-Q) from The Globe and Mail including charting and trades.

The race to release world models is on as AI image and video generation company Runway joins an increasing number of startups and Big Tech companies by launching its first one. Dubbed GWM-1, the model ...

Amazon has announced a new family of frontier artificial intelligence models—and a new way for customers to build frontier models of their own. The ecommerce giant announced the second generation of ...

Good morning, everyone, and welcome to Insulet's 2025 Investor Day. I'm Clare Trachtman, Vice President of Investor Relations. And on behalf of the entire team, I'd like to thank you all for joining ...

Insulet (NASDAQ:PODD) has outperformed the market over the past 15 years by 11.66% on an annualized basis producing an average annual return of 23.78%. Currently, Insulet has a market capitalization ...